First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
More stories
Auto Casualty
CE Webinar
Navigating Michigan’s No-Fault Auto Fee Schedule Four Months In [On-Demand Webinar]
On-Demand
On July 2, 2021, Michigan’s new auto fee schedule went into effect for services rendered on or after that date.
Workers' Comp
News Release
App Helps Keep Work Environments Safe From COVID-19
Safe2Work App Employers are looking for efficient ways to keep work environments safe from COVID-19.
Workers' Comp
Article
Catastrophic Claims Often Require Nuanced Solutions
In workers’ compensation, catastrophic injuries transpire with relatively low frequency.
Mitchell
News Release
Mitchell Diagnostics Platform Surpasses 3 Million Scans
SAN DIEGO, CA—November 3, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
Mitchell
News Release
Mitchell Named Official Technology Provider of the Vale Paintless Dent Repair (PDR) Technician Certification Program
SAN DIEGO, CA—October 26, 2021—Mitchell, a leading provider of technology, connectivity and information solutions to the
Enlyte
Article
FDA Approves Combination NSAID/Opioid Seglentis
On October 18, 2021, Seglentis was approved by the U.S. Food and Drug Administration (FDA).